Spanios

Spanios' patented Patient-Derived 3D Tumoroid (PDT) platform introduces patient diversity and biological complexity of solid tumors into the early stages of drug development. This unique platform overcomes the limitations of traditional methods, such as xenografts and animal models, by creating a resilient replica of the host tumor environment. These models include the tumor and its microenvironment grown together to form tumoroids that respond to treatments in ways similar to those of patients. This enables scientists to rapidly explore new therapeutic approaches, bringing hope to millions of patients and focusing on identifying new pathways to bring the best treatments to the clinic.